Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
HPS1 mutations cause HPS-1 disease, and ADTB3A mutations cause HPS-2 disease, which is known to involve abnormal intracellular vesicle formation.
|
11590544 |
2001 |
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
(2) Disorders of melanosome formation in the melanocyte: Hermansky-Pudlak syndrome 1-7 (HPS1-7); Chediak-Higashi syndrome 1 (CHS1).
|
15452859 |
2004 |
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
Genetic counseling of 51 Chinese OCA families (39 OCA-1 with mutations in the TYR gene, 6 OCA-2 with mutations in the OCA2 gene, 4 OCA-4 with mutations in the SLC45A2 gene, 1 HPS-1 (Hermansky-Pudlak syndrome-1) with mutation in the HPS1 gene, and 1 mixed OCA-1 and OCA-4) led us to perform the prenatal genetic testing of OCA using amniotic fluid cells through the implementation of our optimized strategy.
|
26165494 |
2015 |
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
|
0.940 |
Biomarker
|
disease |
BEFREE |
One causative gene is HPS1, coding for a protein of unknown function and resulting in HPS-1 disease, common in northwest Puerto Rico.
|
11592818 |
2001 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
HPS4 protein forms a BLOC-3 complex with HPS1, another <i>HPS</i> gene product, and the complex has been proposed to function as a guanine nucleotide exchange factor (GEF) for RAB32, a member of the Rab small GTPase family (Rab32), and Rab38 (Rab32/38-GEF) and also as a Rab9 effector.
|
30837268 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate this in patient-derived cell lines for two diseases: limb-girdle muscular dystrophy type 2G (LGMD2G)<sup>1</sup> and Hermansky-Pudlak syndrome type 1 (HPS1)<sup>2</sup>.
|
30944467 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene.
|
10411151 |
1999 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hps1 is essential for proper biogenesis of lysosome-related organelles and loss of its function leads to a disease called type 1 Hermansky-Pudlak Syndrome (HPS).
|
25375251 |
2014 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To compare clinically 2 different subtypes of Hermansky-Pudlak syndrome (HPS), type 1 (HPS-1) and type 3 (HPS-3).
|
15288994 |
2004 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking.
|
9759648 |
1998 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
High frequency of Hermansky-Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein.
|
16185271 |
2005 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Whole exome or direct sequencing showed that two of the children had Hermansky-Pudlak syndrome (HPS) type-1 (HPS-1), one had HPS-3, one had HPS-4, and four had non-syndromic oculocutaneous albinism associated with TYR variants (OCA1).
|
30791930 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome (HPS) is a rare disease caused by mutations in the genes coding for various HPS proteins.
|
31776394 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome type-1 (HPS-1) is an autosomal recessive disorder caused by mutations in HPS1 which result in reduced expression of the HPS-1 protein, defective lysosome-related organelle (LRO) transport and absence of platelet delta granules.
|
27459687 |
2016 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
This retrospective review identified 170 individuals with a specific type of albinism identified by mutation(s) in a gene known to cause albinism (for OCA1, OCA2, and Hermansky-Pudlak syndrome ([HPS]) or a specific phenotype (white hair and no melanin pigment in OCA1A; pigmentary mosaicism in the obligate carriers for males with OA1).
|
27647118 |
2016 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Recently, we have identified subjects with one HPS1 heterozygous mutation displaying significant reductions in PDG without the clinical phenotype of Hermansky-Pudlak syndrome.
|
15020272 |
2004 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene.
|
9182823 |
1997 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The patient proved to have a compound heterozygous mutation of the HPS1 gene resulting in Hermansky-Pudlak syndrome type 1.
|
30634918 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome (HPS) is a set of genetically heterogeneous diseases caused by mutations in one of nine known HPS genes.
|
23893484 |
2013 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in six genes have been reported to be responsible for different types of oculocutaneous and ocular albinism, including the tyrosinase gene (TYR) and OCA1 (MIM# 203100), the OCA2 gene and OCA2 (MIM# 203200), the tyrosinase-related protein-1 gene (TYRP1) and OCA3 (MIM# 203290), the HPS gene and Hermansky-Pudlak syndrome (MIM# 203300), the CHS gene (CHS1), and Chediak-Higashi syndrome (MIM# 214500), and the X-linked ocular albinism gene and OA1 (MIM#300500).
|
10094567 |
1999 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.
|
31619213 |
2019 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).
|
27345974 |
2016 |
Hermanski-Pudlak Syndrome
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant.
|
25117010 |
2014 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome-type 3 (HPS-3) is a relatively mild subtype of HPS with minimal cutaneous and ocular depigmentation.
|
15632015 |
2005 |
Hermanski-Pudlak Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4.
|
12847290 |
2003 |